Ebos GroupASX:EBO +0.30%77 Quick Ratio is 0.74 as of Dec. 2025, which is at its 10-year median of 0.74. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 120 Medical Distribution companies, Ebos Group ranks worse than 78.33% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Ebos Group's quick ratio for the quarter that ended in Dec. 2025 was 0.74.
Ebos Group has a quick ratio of 0.74. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Ebos Group's Quick Ratio or its related term are showing as below:
ASX:EBO'
s Quick Ratio Range Over the Past 10 Years
Min: 0.57 Med: 0.74 Max: 0.92
Current: 0.74
During the past 13 years, Ebos Group's highest Quick Ratio was 0.92. The lowest was 0.57. And the median was 0.74.
ASX:EBO's Quick Ratio is ranked worse than 78.33% of 120
companies
in the Medical Distribution industry
Industry Median: 1.055
vs ASX:EBO: 0.74
Ebos Group (ASX:EBO) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Ebos Group Quick Ratio Related Terms
Ebos Group Quick Ratio Historical Data
* Premium members only.
The historical data trend for Ebos Group's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Quick Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Ebos Group's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Ebos Group's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a Quick Ratio of 0.74 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ebos Group and its competitors. This is near median its historical median of 0.74. Over the past decade, Ebos Group's Quick Ratio has ranged from 0.57 to 0.92. According to the industry distribution chart, Ebos Group ranks #94 out of 120 companies in the Medical Distribution industry, placing it in the top 78.3%.
Is Ebos Group's Quick Ratio too high?
Ebos Group's current Quick Ratio of 0.74 is near median its 10-year median of 0.74. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 0.92. The Medical Distribution industry median Quick Ratio is 1.06. Ebos Group's value of 0.74 is 29.9% below this industry median. Based on the distribution chart, Ebos Group ranks #94 out of 120 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Quick Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #94 out of 120 companies for Quick Ratio. This places Ebos Group in the lower half of its industry. The industry median Quick Ratio is 1.06. Ebos Group's value of 0.74 is 29.9% below this benchmark. Historically, Ebos Group's own Quick Ratio has ranged from 0.57 to 0.92 over the past decade. While the company's 10-year median is 0.74 vs. the industry median of 1.06, Ebos Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Distribution company?
The median Quick Ratio among Medical Distribution companies is 1.06, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current Quick Ratio of 0.74 is 29.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median Quick Ratio is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current Quick Ratio is 0.74, which is near median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current Quick Ratio is 0.74, which is near median its 10-year median of 0.74 and 29.9% below the Medical Distribution industry median of 1.06. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Quick Ratio is 0.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
Quick Ratio: 0.74 (near median its 10-year median of 0.74)
GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
Industry Position: 29.9% below the Medical Distribution median (#94 of 120)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
